Viking Therapeutics
VKTX
VKTX
156 hedge funds and large institutions have $374M invested in Viking Therapeutics in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 43 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
156
Holders Change
-8
Holders Change %
-4.88%
% of All Funds
3.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
50
Reduced
43
Closed
24
Calls
$19.5M
Puts
$12.3M
Net Calls
+$7.2M
Net Calls Change
-$4.09M
Top Buyers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$19.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.9M |
| 3 |
Citigroup
New York
|
+$3.97M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.42M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$2.42M |
Top Sellers
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$17.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8.6M |
| 3 |
CCI
Columbus Circle Investors
|
-$3.57M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$3.09M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.92M |
